These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10328590)

  • 21. Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses.
    Puumalainen AM; Vapalahti M; Agrawal RS; Kossila M; Laukkanen J; Lehtolainen P; Viita H; Paljärvi L; Vanninen R; Ylä-Herttuala S
    Hum Gene Ther; 1998 Aug; 9(12):1769-74. PubMed ID: 9721087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy for atherosclerotic cardiovascular disease: a time for optimism and caution.
    O'Brien T; Simari RD
    Mayo Clin Proc; 2000 Aug; 75(8):831-4. PubMed ID: 10943238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiogenesis in malignant gliomas.
    Plate KH; Risau W
    Glia; 1995 Nov; 15(3):339-47. PubMed ID: 8586468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vector delivery methods and targeting strategies for gene therapy of brain tumors.
    Rainov NG; Kramm CM
    Curr Gene Ther; 2001 Nov; 1(4):367-83. PubMed ID: 12109063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenovirus-mediated p53 gene therapy for human gliomas.
    Lang FF; Yung WK; Sawaya R; Tofilon PJ
    Neurosurgery; 1999 Nov; 45(5):1093-104. PubMed ID: 10549925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions.
    Crystal RG; Harvey BG; Wisnivesky JP; O'Donoghue KA; Chu KW; Maroni J; Muscat JC; Pippo AL; Wright CE; Kaner RJ; Leopold PL; Kessler PD; Rasmussen HS; Rosengart TK; Hollmann C
    Hum Gene Ther; 2002 Jan; 13(1):65-100. PubMed ID: 11779413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherosclerosis and angiogenesis. Its pathophysiological significance in humans as well as in an animal model induced by the gene transfer of vascular endothelial growth factor.
    Sueishi K; Yonemitsu Y; Nakagawa K; Kaneda Y; Kumamoto M; Nakashima Y
    Ann N Y Acad Sci; 1997 Apr; 811():311-22; 322-4. PubMed ID: 9186607
    [No Abstract]   [Full Text] [Related]  

  • 29. Gene- and viral-based therapies for brain tumors.
    Asadi-Moghaddam K; Chiocca EA
    Neurotherapeutics; 2009 Jul; 6(3):547-57. PubMed ID: 19560744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy as an adjuvant treatment for malignant gliomas: from bench to bedside.
    Germano IM; Binello E
    J Neurooncol; 2009 May; 93(1):79-87. PubMed ID: 19430884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The growth inhibition of hepatoma by gene transfer of antisense vascular endothelial growth factor.
    Kang MA; Kim KY; Seol JY; Kim KC; Nam MJ
    J Gene Med; 2000; 2(4):289-96. PubMed ID: 10953920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene therapy for malignant gliomas.
    Alavi JB; Eck SL
    Hematol Oncol Clin North Am; 1998 Jun; 12(3):617-29. PubMed ID: 9684101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scatter factor/hepatocyte growth factor gene transfer increases rat blood-glioma barrier permeability.
    Book AA; Ranganathan S; Abounader R; Rosen E; Laterra J
    Brain Res; 1999 Jul; 833(2):173-80. PubMed ID: 10375692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining gene transfer before expecting gene therapy: putting the horse before the cart.
    Pislaru S; Janssens SP; Gersh BJ; Simari RD
    Circulation; 2002 Jul; 106(5):631-6. PubMed ID: 12147548
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis?
    Weindel K; Moringlane JR; Marmé D; Weich HA
    Neurosurgery; 1994 Sep; 35(3):439-48; discussion 448-9. PubMed ID: 7528359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment.
    Guo P; Hu B; Gu W; Xu L; Wang D; Huang HJ; Cavenee WK; Cheng SY
    Am J Pathol; 2003 Apr; 162(4):1083-93. PubMed ID: 12651601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiangiogenic therapy in malignant glioma: promise and challenge.
    Sathornsumetee S; Rich JN
    Curr Pharm Des; 2007; 13(35):3545-58. PubMed ID: 18220791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-angiogenic treatment strategies for malignant brain tumors.
    Kirsch M; Schackert G; Black PM
    J Neurooncol; 2000; 50(1-2):149-63. PubMed ID: 11245274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy for collateral vessel development.
    Melillo G; Scoccianti M; Kovesdi I; Safi J; Riccioni T; Capogrossi MC
    Cardiovasc Res; 1997 Sep; 35(3):480-9. PubMed ID: 9415292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trials with retrovirus mediated gene therapy--what have we learned?
    Rainov NG; Ren H
    J Neurooncol; 2003 Dec; 65(3):227-36. PubMed ID: 14682373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.